References
- RaherisonCGirodetPOEpidemiology of COPDEur Respir Rev20091811421322120956146
- RennardSIDrummondMBEarly chronic obstructive pulmonary disease: definition, assessment, and preventionLancet201538599791778178825943942
- FletcherCPetoRThe natural history of chronic airflow obstructionBMJ19771607716451648871704
- LangePCelliBAgustiALung-function trajectories leading to chronic obstructive pulmonary diseaseN Engl J Med2015373211112226154786
- VestboJEdwardsLDScanlonPDChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
- O’DonnellDELavenezianaPPhysiology and consequences of lung hyperinflation in COPDEur Respir Rev2006151006167
- O’DonnellDEGuenetteJAMaltaisFWebbKADecline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exerciseChest2012141375376221852298
- ZamanMMahmoodSAltayehALow inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbationAm J Med Sci2010339541141420375693
- CasanovaCCoteCde TorresJPInspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171659159715591470
- ViegiGPistelliFSherrillDLMaioSBaldacciSCarrozziLDefinition, epidemiology and natural history of COPDEur Respir J2007305993101317978157
- ParkTSLeeJSSeoJBKOLD Study GroupStudy design and outcomes of Korean obstructive lung disease (KOLD) cohort studyTuberc Respir Dis (Seoul)201476416917424851130
- VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- OhYMJeongBHWooSYKOLD Study GroupAssociation of plasma adipokines with chronic obstructive pulmonary disease severity and progressionAnn Am Thorac Soc20151271005101226010877
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J200526351152216135736
- CrieeCPSorichterSSmithHJBody plethysmographyits principles and clinical useRespir Med2011105795997121356587
- ChoiJKPaekDLeeJONormal predictive values of spirometry in Korean populationTuberc Respir Dis2005583230242
- SongEHOhYMHongSBSelection of reference equations for lung volumes and diffusing capacity in KoreaTuberc Respir Dis2006613218226
- QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for steel and coal. Official statement of the European Respiratory SocietyEur Respir J Suppl1993165408499054
- global Initiative for Chronic Obstructive Lung Disease (GOLD) [webpage on the Internet]Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease [Updated 2016] Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016Accessed November 14, 2016
- WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
- FitzmauriceGMRavichandranCA primer in longitudinal data analysisCirculation2008118192005201018981315
- MarinJMCarrizoSJGasconMSanchezAGallegoBCelliBRInspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116361395139911371407
- KloosterKten HackenNHHartmanJESciurbaFCKerstjensHASlebosDJDetermining the role of dynamic hyperinflation in patients with severe chronic obstructive pulmonary diseaseRespiration201590430631326352833
- SatakeMShioyaTUemuraSDynamic hyperinflation and dyspnea during the 6-minute walk test in stable chronic obstructive pulmonary disease patientsInt J Chron Obstruct Pulmon Dis20151015315825632228
- ThomasMDecramerMO’DonnellDENo room to breathe: the importance of lung hyperinflation in COPDPrim Care Respir J201322110111123429861
- RamonMAFerrerJGimeno-SantosEPAC-COPD Study GroupInspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPDRespirology201621347648226714424
- FrenchABalfeDMirochaJMFalkJAMosenifarZThe inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2015101305131226203237
- DeesomchokAWebbKAForkertLLung hyperinflation and its reversibility in patients with airway obstruction of varying severityCOPD20107642843721166631
- CorbinRPLovelandMMartinRRMacklemPTA four-year follow-up study of lung mechanics in smokersAm Rev Respir Dis19791202293304475151
- CortopassiFCelliBDivoMPinto-PlataVLongitudinal changes in handgrip strength, hyperinflation, and 6-minute walk distance in patients with COPD and a control groupChest2015148498699425996450
- CelliBRDecramerMLystigTKestenSTashkinDPLongitudinal inspiratory capacity changes in chronic obstructive pulmonary diseaseRespir Res2012136622866681
- Orozco-LeviMStructure and function of the respiratory muscles in patients with COPD: impairment or adaptation?Eur Respir J Suppl20034641s51s14621106
- VestboJAndersonJABrookRDSUMMIT InvestigatorsFluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trialLancet2016387100301817182627203508
- TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
- CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
- HartmanJETen HackenNHKloosterKBoezenHMde GreefMHSlebosDJThe minimal important difference for residual volume in patients with severe emphysemaEur Respir J20124051137114122441742
- KannerREAnthonisenNRConnettJELower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health studyAm J Respir Crit Care Med2001164335836411500333
- DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
- HalpinDMDecramerMCelliBKestenSLiuDTashkinDPExacerbation frequency and course of COPDInt J Chron Obstruct Pulmon Dis2012765366123055714
- WedzichaJABrillSEAllinsonJPDonaldsonGCMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Med20131118123945277